Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. The company also offers clean utility equipment and chemical pharmaceutical preparation systems; bioprocess equipment and systems; clean room, automation control, and monitoring systems; powder and solid equipment and systems; aseptic freeze-drying, filling, and visual inspection solutions; pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; and laboratory one-stop solutions. In addition, it provides consulting and engineering technical services; compliance and validation services; digital factory services; clean room HVAC/EMS/BMS services; and upgrade, retrofit, and maintenance services. Further, it engages in life science consumables, advanced therapies, and advanced bioprocessing technologies, as well as engineering design services. Austar Lifesciences Limited was founded in 1991 and is headquartered in Shanghai, China.
Frequently asked questions
What sector does Austar Lifesciences Ltd (6118) operate in?
Austar Lifesciences Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Austar Lifesciences Ltd (6118) current stock price?
As of the latest data, Austar Lifesciences Ltd stock price is HK$0.72, with a previous close of HK$0.70. Austar Lifesciences Ltd gained HK$0.02 in the last trading session, representing a 2.86% increase.
What is Austar Lifesciences Ltd (6118) current market capitalization?
Austar Lifesciences Ltd market cap is approximately 369.06 million.
What is Austar Lifesciences Ltd (6118) EBITDA?
Austar Lifesciences Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 30.98 million.
Does Austar Lifesciences Ltd (6118) pay dividends?
No. Austar Lifesciences Ltd does not pay a dividend.
What is Austar Lifesciences Ltd (6118) beta (volatility) score?
Austar Lifesciences Ltd has a beta of 0.864, meaning its volatility is roughly in line with the market.
